Osaic Holdings
DSGN icon

Osaic Holdings’s Design Therapeutics DSGN Stock Holding History

Osaic Holdings’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26K Buy
306
+296
+2,960% +$3K ﹤0.01% 6867
2025
Q4 		$94 Buy
+10
New +$78 ﹤0.01% 7656
2025
Q3 		– Sell
-10
Closed -$34 – 7919
2025
Q2 		$34 Sell
10
-39
-80% -$146 ﹤0.01% 7640
2025
Q1 		$189 Sell
49
-24
-33% -$115 ﹤0.01% 7171
2024
Q4 		$450 Buy
73
+63
+630% +$365 ﹤0.01% 7042
2024
Q3 		$54 Buy
+10
New +$47 ﹤0.01% 7291
2024
Q1 		– Sell
-15
Closed -$35 – 7241
2023
Q4 		$35 Sell
15
-200
-93% -$458 ﹤0.01% 7182
2023
Q3 		$505 Sell
215
-17
-7% -$79 ﹤0.01% 6986
2023
Q2 		$1.46K Buy
232
+29
+14% +$177 ﹤0.01% 6766
2023
Q1 		$1.17K Sell
203
-17
-8% -$127 ﹤0.01% 6897
2022
Q4 		$2K Sell
220
-101
-31% -$1.37K ﹤0.01% 6635
2022
Q3 		$5K Buy
321
+88
+38% +$1.75K ﹤0.01% 6350
2022
Q2 		$4K Hold
233
– – ﹤0.01% 6575
2022
Q1 		$4K Buy
233
+28
+14% +$429 ﹤0.01% 6584
2021
Q4 		$5K Buy
205
+109
+114% +$1.87K ﹤0.01% 6621
2021
Q3 		$2K Hold
96
– – ﹤0.01% 6840
2021
Q2 		$2K Buy
96
+60
+167% +$1.51K ﹤0.01% 6693
2021
Q1 		$1K Buy
+36
New +$1.21K ﹤0.01% 6633

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings's DSGN Position: Q1 2026 in Review

Osaic Holdings increased its Design Therapeutics (DSGN) stake by 2,960% in Q1 2026, buying an estimated $3K and bringing the position to 306 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #6867.

Osaic Holdings first reported a position in DSGN in Q1 2021 and has held it in 18 quarters since. The position peaked at $5K in Q3 2022. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Osaic Holdings held 306 shares of Design Therapeutics worth $3.26K as of Q1 2026.
  • Osaic Holdings bought 296 Design Therapeutics shares in Q1 2026, an estimated $3K.
  • Design Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6867 holding.
  • Osaic Holdings first reported a position in Design Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • Osaic Holdings's Design Therapeutics position peaked at $5K in Q3 2022.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.